Research source
AI identified a new gene-based risk model to predict outcomes in acute myeloid leukemia.
Based on Machine learning-based integration develops a novel lysosome-related prognostic signature associated with prognosis and immune infiltration landscape in acute myeloid leukemia.
Published by Discover oncologyJun 23, 2026
Peer-reviewed paperMedium evidenceHuman study
What researchers observed
Study developed and validated a gene-based AI model to predict prognosis and immune features in leukemia patients.
What this could mean
This could help researchers better measure prognosis and immune involvement in leukemia, improving future study designs and treatment testing if confirmed further.
What researchers still need to learn
Researchers still need to learn whether this model can improve patient treatment or outcomes in real clinical settings.